Detalhe da pesquisa
1.
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR).
Eur Respir J
; 61(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229048
2.
Long-term safety of brazikumab in the open-label period of a randomized phase 2a study of patients with Crohn's disease.
BMC Gastroenterol
; 23(1): 451, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38124112
3.
Mathematical Modelling of Alternative Pathway of Complement System.
Bull Math Biol
; 82(2): 33, 2020 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32062771
4.
Correction to: Mathematical Modelling of Alternative Pathway of Complement System.
Bull Math Biol
; 84(1): 18, 2021 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34923606
5.
Ex vivo expansion of human outgrowth endothelial cells leads to IL-8-mediated replicative senescence and impaired vasoreparative function.
Stem Cells
; 31(8): 1657-68, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23629812
6.
CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
Breast Cancer Res
; 14(3): R84, 2012 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22621373
7.
Mathematical Modeling of Complement Pathway Dynamics for Target Validation and Selection of Drug Modalities for Complement Therapies.
Front Pharmacol
; 13: 855743, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35517827
8.
PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy.
Oncotarget
; 7(7): 7885-98, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26799286
9.
Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
Oncotarget
; 5(13): 4895-908, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24970800
10.
Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.
Eur Urol
; 64(2): 177-88, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22939387